OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Shruti Joshi, Trisha Singh, David E. Newby, et al.
Heart (2021) Vol. 107, Iss. 13, pp. 1032-1038
Open Access | Times Cited: 137
Shruti Joshi, Trisha Singh, David E. Newby, et al.
Heart (2021) Vol. 107, Iss. 13, pp. 1032-1038
Open Access | Times Cited: 137
Showing 26-50 of 137 citing articles:
Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Hufang Zhou, Wenhua Peng, Fuyao Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Hufang Zhou, Wenhua Peng, Fuyao Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 20
SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Noor ul Amin, Faiza Sabir, Talal Bin Amin, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2356-2356
Open Access | Times Cited: 20
Noor ul Amin, Faiza Sabir, Talal Bin Amin, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2356-2356
Open Access | Times Cited: 20
Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors
Ariana P. Vargas-Delgado, Estefania Arteaga Herrera, Cesar Tumbaco Mite, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4144-4144
Open Access | Times Cited: 12
Ariana P. Vargas-Delgado, Estefania Arteaga Herrera, Cesar Tumbaco Mite, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4144-4144
Open Access | Times Cited: 12
Clinical pharmacology of SGLT-2 inhibitors in heart failure
Maria Velliou, Effie Polyzogopoulou, Ioannis Ventoulis, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 149-160
Closed Access | Times Cited: 11
Maria Velliou, Effie Polyzogopoulou, Ioannis Ventoulis, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 149-160
Closed Access | Times Cited: 11
The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
Cristina Bică, Valeria-Anca Pietroșel, Teodor Salmen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7184-7184
Open Access | Times Cited: 11
Cristina Bică, Valeria-Anca Pietroșel, Teodor Salmen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7184-7184
Open Access | Times Cited: 11
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Patrizia Natale, Suetonia C. Palmer, Sankar D. Navaneethan, et al.
Cochrane library (2024) Vol. 2024, Iss. 5
Closed Access | Times Cited: 4
Patrizia Natale, Suetonia C. Palmer, Sankar D. Navaneethan, et al.
Cochrane library (2024) Vol. 2024, Iss. 5
Closed Access | Times Cited: 4
Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future
Ying Jie Chee, Rinkoo Dalan
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1386-1386
Open Access | Times Cited: 4
Ying Jie Chee, Rinkoo Dalan
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1386-1386
Open Access | Times Cited: 4
The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
Chien-Yin Kuo, Sing‐Hua Tsou, Edy Kornelius, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Chien-Yin Kuo, Sing‐Hua Tsou, Edy Kornelius, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Ventricular remodeling with dapagliflozin in elderly women with HFpEF--a single center prospective study
Jiajia Huang, Shu Xu, A. Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Jiajia Huang, Shu Xu, A. Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Therapeutic Ketosis for Heart Failure: A State-of-the-Art-Review
Nandan Kodur, Christopher Nguyen, W.H. Wilson Tang
Journal of Cardiac Failure (2025)
Open Access
Nandan Kodur, Christopher Nguyen, W.H. Wilson Tang
Journal of Cardiac Failure (2025)
Open Access
Novel impact of metal ion-induced cell death on diabetic cardiomyopathy pathogenesis and therapy
Jingjing Jiang, Shengnan Hu, Kaibo Hu, et al.
APOPTOSIS (2025)
Closed Access
Jingjing Jiang, Shengnan Hu, Kaibo Hu, et al.
APOPTOSIS (2025)
Closed Access
Dapagliflozin Attenuates Myocardial Inflammation and Apoptosis after Coronary Microembolization in Rats by Regulating the SIRT1/NF-κB Signaling Pathway
Tao Li, Chun Luo, Ze-Qiang Yi, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Tao Li, Chun Luo, Ze-Qiang Yi, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Mitochondrial Changes Induced by SGLT2i in Lymphocytes from Diabetic Kidney Transplant Recipients: A Pilot Study
Isabel Pérez-Flores, Andrea R. López‐Pastor, Ulises Gómez-Pinedo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3351-3351
Open Access
Isabel Pérez-Flores, Andrea R. López‐Pastor, Ulises Gómez-Pinedo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3351-3351
Open Access
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial
Zhuoshan Huang, Rui Fan, Shaozhao Zhang, et al.
ESC Heart Failure (2025)
Open Access
Zhuoshan Huang, Rui Fan, Shaozhao Zhang, et al.
ESC Heart Failure (2025)
Open Access
Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
Hwa Yeon Ko, Kyungyeon Jung, Yongtai Cho, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Hwa Yeon Ko, Kyungyeon Jung, Yongtai Cho, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Type 2 diabetes mellitus – conventional therapies and future perspectives in innovative treatment
Barbara Gieroba, Adrianna Kryska, Anna Sroka‐Bartnicka
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102037-102037
Closed Access
Barbara Gieroba, Adrianna Kryska, Anna Sroka‐Bartnicka
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 102037-102037
Closed Access
Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
Hidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4416-4416
Open Access | Times Cited: 27
Hidekatsu Yanai, Mariko Hakoshima, Hiroki Adachi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4416-4416
Open Access | Times Cited: 27
Exploring the Correlation and Protective Role of Diabetes Mellitus in Aortic Aneurysm Disease
Divyatha Arun, Wahaj Munir, Lara Victoria Schmitt, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 24
Divyatha Arun, Wahaj Munir, Lara Victoria Schmitt, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 24
Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
Cesar Lam
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Cesar Lam
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Experimental Design Approach for Quantitative Expressions of Simultaneous Quantification of Two Binary Formulations Containing Remogliflozin and Gliptins by RP-HPLC
Mahesh Attimarad, Katharigatta N. Venugopala, Anroop B. Nair, et al.
Separations (2022) Vol. 9, Iss. 2, pp. 23-23
Open Access | Times Cited: 16
Mahesh Attimarad, Katharigatta N. Venugopala, Anroop B. Nair, et al.
Separations (2022) Vol. 9, Iss. 2, pp. 23-23
Open Access | Times Cited: 16
An Experimental Design Approach to Quantitative Expression for Quality Control of a Multicomponent Antidiabetic Formulation by the HILIC Method
Mahesh Attimarad, Katharigatta N. Venugopala, Muhammad Shahzad Chohan, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3135-3135
Open Access | Times Cited: 14
Mahesh Attimarad, Katharigatta N. Venugopala, Muhammad Shahzad Chohan, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3135-3135
Open Access | Times Cited: 14
Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction
Sabina Andreea Leancă, Irina Afrăsânie, Daniela Crișu, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 9
Sabina Andreea Leancă, Irina Afrăsânie, Daniela Crișu, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 9
From Cardiorenal Syndrome to Chronic Cardiovascular and Kidney Disorder
Carmine Zoccali, Francesca Mallamaci, Jean‐Michel Halimi, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 6, pp. 813-820
Closed Access | Times Cited: 9
Carmine Zoccali, Francesca Mallamaci, Jean‐Michel Halimi, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 19, Iss. 6, pp. 813-820
Closed Access | Times Cited: 9
Benefit of sodium-glucose cotransporter-2 inhibitors on survival outcome is related to the type of heart failure: A meta-analysis
Lingyue Zhao, Wenqin Guo, Weichao Huang, et al.
Diabetes Research and Clinical Practice (2022) Vol. 187, pp. 109871-109871
Open Access | Times Cited: 13
Lingyue Zhao, Wenqin Guo, Weichao Huang, et al.
Diabetes Research and Clinical Practice (2022) Vol. 187, pp. 109871-109871
Open Access | Times Cited: 13
